WUXI TIDES

Live / Registered — Registered (as of 23 Sept 2025)

What this means for you

Registered since 23 Sept 2025. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97775103
Registration number
7961204
Mark type
Stylized text
Filed
31 Jan 2023
Published for opposition
12 Mar 2024
Registered
23 Sept 2025
Attorney of record
Jonathan M. Rixen

Goods and services

  • Class 005 — Pharmaceuticals: Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cancer, autoimmune disease, coagulation disorder, infectious disease; Medicines for human purposes, namely, medicines for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Raw material medicine, namely, medicines for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Pharmaceutical preparations, for the treatment of cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders; pharmaceutical preparations, namely, antivirals; Chemico-pharmaceutical preparations for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Biological preparations for medical purposes for the treatment of cancer; Chemical preparations for the diagnosis of pregnancy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancers, inflammatory diseases, autoimmune diseases, infectious diseases, and coagulation disorders healthcare and clinical applications; Chemical preparations for medical purposes, namely, chemical reagents for medical purposes; Chemical preparations for medical purposes for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Diagnostic preparations for medical purposes; Nutritional supplements; Drugs for medical purposes for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases; Reagent paper for medical purposes; Medical reagent; Disinfectants for hygiene purposes; Cultures of microorganisms for medical use; Biomedicines for the treatment of cancer, cardiovascular, hematologic, neurological,; gastrointestinal and genetic diseases; Adjuvants for medical purposes; Vaccines; Veterinary preparations for the treatment of cancer, cardiovascular, hematologic, neurological, gastrointestinal and genetic diseases
  • Class 042 — Scientific and technological services: Computer programming; Material testing; Technical research in the field of pharmaceutical studies; Research and development of new products for others; Technology consultancy in the field of cybersecurity; Chemical analysis; Chemistry services, namely, chemistry consultation; Chemical research; Biological research; conducting clinical trials for others, being for scientific and medical research; Quality checking and testing, namely, quality control for others; Scientific laboratory services; Genome structure and function analysis; Gene screening, namely, DNA screening for scientific research purpose; Biomedical research services; Stem cell research service; Drug research and development services, namely, pharmaceutical research; cell culture services for scientific research purposes, for others; Design and development of computer hardware and software; Development and creation of computer programs for data processing; Computer programming in the field of medical treatment; Product quality testing; assessment of quality of products; Scientific research; Surveying; Bacteriological research; The design, production in the nature of design, or maintenance of a computer program; Computer software design; Computer technology consultancy in the field of engineering; Information technology consulting relating to computer network design; Artificial intelligence technology consulting; Research on artificial intelligence technology; Research and development of new products; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Drug evaluation, namely, pharmaceutical product evaluation; Vaccine research and development services; Cancer medicine research; Biotechnology research; Drug testing being testing of pharmaceuticals; Pharmaceutical research; Cancer scientific research for medical purposes; Development and Test of Chemical production methods; Implementing of early evaluation in the field of new drugs, namely, product quality testing; Biochemical research and analysis; Chemical analysis evaluation service; Chemical synthesis evaluation service; scientific research of the mode of action of chemical combinations on animals

Owner

Prosecution history

  • 23 Sept 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 23 Sept 2025 — REGISTERED-PRINCIPAL REGISTER
  • 03 Sept 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 29 Aug 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 08 Aug 2025 — STATEMENT OF USE PROCESSING COMPLETE
  • 04 Jul 2024 — USE AMENDMENT FILED
  • 08 Aug 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 22 Jan 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 22 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 22 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 22 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 04 Jul 2024 — TEAS STATEMENT OF USE RECEIVED
  • 07 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 12 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 12 Mar 2024 — PUBLISHED FOR OPPOSITION

View this trademark record on Marksy